Showing results (91-100 of 152) with videos related to
Sort By:
Pageof 16
Acta Dermato-Venereologica|August 10, 2012
A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp healthJames R Schwartz, Andrew G Messenger, Antonella Tosti, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2020
An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17FChunsheng Zhou, Leticia Monin, Rachael Gordon, et al.JCI Insight|October 5, 2018
High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areataAnnemieke de Jong, Ali Jabbari, Zhenpeng Dai, et al.American Journal of Human Genetics|January 20, 2007
Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areataAmalia Martinez-Mir, Abraham Zlotogorski, Derek Gordon, et al.Nature Immunology|January 8, 2008
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesisJessica Strid, Scott J Roberts, Renata B Filler, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2014
Targeting antigens through blood dendritic cell antigen 2 on plasmacytoid dendritic cells promotes immunologic toleranceCraig P Chappell, Natalia V Giltiay, Kevin E Draves, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10Botond Z Igyarto, Matthew C Jenison, Jan C Dudda, et al.The New England Journal of Medicine|September 8, 2010
Bone marrow transplantation for recessive dystrophic epidermolysis bullosaJohn E Wagner, Akemi Ishida-Yamamoto, John A McGrath, et al.Blood|October 15, 2010
Langerhans cells are not required for graft-versus-host diseaseHongmei Li, Daniel H Kaplan, Catherine Matte-Martone, et al.The New England Journal of Medicine|March 25, 2022
Two Phase 3 Trials of Baricitinib for Alopecia AreataBrett King, Manabu Ohyama, Ohsang Kwon, et al.Pageof 16